After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
A broad crypto market sell-off has dragged AI-linked tokens to one of their steepest weekly declines in recent memory, erasing billions in value. Despite the price pain, key infrastructure projects in the decentralized AI and agent ecosystem continue to advance.
Amid a sharp pullback in gold and silver prices, NovaGold Chairman Thomas Kaplan remains steadfastly bullish, telling Business Insider he views the volatility as a temporary setback on a path to record highs.
In a significant vote of confidence for Latin America's premier shale play, investment firm PING Capital Management has substantially increased its holding in Argentina-focused Vista Energy, underscoring a strategic focus on operational execution over mere commodity price speculation.
As gold and silver prices swing wildly from record highs to sudden slumps, experts urge caution for individuals looking to cash in. We examine the market forces at play and the crucial considerations before selling your heirlooms or investments.
From Denny's to Outback Steakhouse, a wave of closures is sweeping through America's familiar dining landscape. Experts point to a perfect storm of inflation, shifting consumer habits, and financial pressures reshaping where we eat.
Regular savings accounts offer attractive rates for disciplined savers, but come with strict rules on monthly deposits and withdrawals. Our guide breaks down the latest deals and what you need to know before committing your cash.
While AI's role in headline-grabbing discoveries like AlphaFold is celebrated, Anthropic is forging a new path. Through partnerships with the Allen Institute and HHMI, the company is embedding Claude AI into the unglamorous, time-consuming groundwork of research—betting that efficiency gains in data analysis and coordination will compress decades of scientific progress.
Despite a challenging year marked by a steep sell-off after disappointing Medicare rate updates, analysts are showing tentative signs of increased confidence in the managed care giant, though a consensus 'Hold' rating prevails.
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.
The trial of Marius Borg Høiby, son of Crown Princess Mette-Marit, opens in Oslo, exposing a profound crisis for the Norwegian monarchy as he faces charges including rape and assault.
The investment fund sold $3.87 million worth of shares in the Argentine bank, reflecting a strategic portfolio adjustment as the lender navigates a challenging economic environment.
Robinhood Markets (HOOD) has captivated a generation of investors, but its soaring valuation and rich multiples are prompting some on Wall Street to sound the alarm for a potential correction.
In a major consolidation move, Eldorado Gold announces a definitive agreement to acquire Canadian copper-gold developer Foran Mining, positioning the combined entity as a significant near-term producer with a diversified North American and European asset base.
Once a high-flying green energy IPO, Plug Power now trades near historic lows. While its technology powers giants like Amazon and Walmart, mounting losses and a shifting political landscape pose existential questions about its path to profitability.
While Viatris shares have edged past the broader market over the past year, analysts maintain a guarded stance, balancing solid fundamentals against recent profitability pressures and a mixed earnings record.
Maine moves to establish a novel regulatory framework for on-demand pay services, while Washington, D.C. debates whether to treat them as loans, highlighting a national struggle to oversee this fast-growing fintech sector.
In a bold marketing move, telehealth company Hims & Hers is leveraging the Super Bowl's massive audience to spotlight healthcare inequality with its 'Rich People Live Longer' campaign. The push comes as the company expands into advanced diagnostics and treatments, while its stock navigates a significant valuation gap after recent volatility.
Corn futures extended their recent slide to start the week, pressured by a stronger dollar and ongoing adjustments in trader positioning. Despite robust export commitments, concerns over South American harvest progress and speculative activity are keeping the market on the back foot.
Soybean markets opened February on a weaker note, extending losses from the previous week as sluggish export sales and advancing harvests in South America weigh on prices. Analysts are watching key USDA data for further direction.
